These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 21269058)

  • 1. Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.
    Kobayashi K; Ohno Y; Takenaka T; Ikeda N; Okada H; Kanno Y; Suzuki H
    Clin Exp Hypertens; 2011; 33(2):100-5. PubMed ID: 21269058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
    Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
    Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
    Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
    Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
    Usui I; Fujisaka S; Yamazaki K; Takano A; Murakami S; Yamazaki Y; Urakaze M; Hachiya H; Takata M; Senda S; Iwata M; Satoh A; Sasaoka T; Ak ND; Temaru R; Kobayashi M
    Diabetes Res Clin Pract; 2007 Aug; 77(2):210-4. PubMed ID: 17240472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
    Shimabukuro M; Tanaka H; Shimabukuro T
    J Hypertens; 2007 Apr; 25(4):841-8. PubMed ID: 17351377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements.
    Nishimura T; Hashimoto J; Ohkubo T; Kikuya M; Metoki H; Asayama K; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 Aug; 27(6):477-89. PubMed ID: 16081340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of insulin resistance and the serum adiponectin level in patients with type 2 diabetes mellitus under the usual antihypertensive dosage of telmisartan treatment.
    Fuke Y; Fujita T; Satomura A; Wada Y; Matsumoto K
    Diabetes Technol Ther; 2010 May; 12(5):393-8. PubMed ID: 20388049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
    Sanchez RA; Masnatta LD; Pesiney C; Fischer P; Ramirez AJ
    J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha.
    Derosa G; Cicero AF; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Ferrari I; Gravina A; Fogari R
    Hypertens Res; 2006 Nov; 29(11):849-56. PubMed ID: 17345784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive and metabolic effects of telmisartan in hypertensive HIV-positive patients.
    Vecchiet J; Ucciferri C; Falasca K; Mancino P; Di Iorio A; De Caterina R
    Antivir Ther; 2011; 16(5):639-45. PubMed ID: 21817185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
    Mori H; Okada Y; Arao T; Nishida K; Tanaka Y
    Adv Ther; 2012 Jul; 29(7):635-44. PubMed ID: 22821644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of telmisartan on insulin resistance and visceral fat distribution in Chinese hypertensive patients with obesity.
    Huang GZ; Tang YH; Wang BY; Zhang B; Hu TJ; Zhang L; Zhang XY; Zhong Y
    Saudi Med J; 2011 Oct; 32(10):1017-21. PubMed ID: 22008920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients.
    Fogari R; Zoppi A; Ferrari I; Mugellini A; Preti P; Lazzari P; Derosa G
    Horm Metab Res; 2009 Dec; 41(12):893-8. PubMed ID: 19708000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.
    Yang Y; Wei RB; Xing Y; Tang L; Zheng XY; Wang ZC; Gao YW; Li MX; Chen XM
    Metabolism; 2013 Dec; 62(12):1858-66. PubMed ID: 24050270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
    Yamana A; Arita M; Furuta M; Shimajiri Y; Sanke T
    Diabetes Res Clin Pract; 2008 Oct; 82(1):127-31. PubMed ID: 18692932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
    Wago T; Yoshimoto T; Akaza I; Tsuchiya K; Izumiyama H; Doi M; Hirata Y
    Hypertens Res; 2010 Aug; 33(8):796-801. PubMed ID: 20555330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan and metabolic syndrome after heart transplantation.
    Luknar M; Goncalvesova E; Lesny P; Fabian J
    Clin Transplant; 2010; 24(1):36-9. PubMed ID: 19222503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring.
    Lacourcière Y; Neutel JM; Davidai G; Koval S
    Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telmisartan 80 mg/hydrochlorothiazide 25 mg provides clinically relevant blood pressure reductions across baseline blood pressures.
    Neldam S; Schumacher H; Guthrie R
    Adv Ther; 2012 Apr; 29(4):327-38. PubMed ID: 22477543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.